Anaphylactic reaction to ranitidine and dexchlorpheniramine.
Thurot-Guillou
C
C
Bourrain
J L
JL
Jacquier
J P
JP
Beani
J C
JC
D000230:Adenocarcinoma / Q000188:drug therapy*; D000707:Anaphylaxis / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage; D002744:Chlorpheniramine / Q000009:adverse effects; D003937:Diagnosis, Differential; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D004638:Emergency Treatment; D016889:Endometrial Neoplasms / Q000188:drug therapy*; D005260:Female; D006633:Histamine Antagonists / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage; D011899:Ranitidine / Q000009:adverse effects; D012882:Skin Tests
D006633:Histamine Antagonists; C018904:dexchlorpheniramine; D002744:Chlorpheniramine; D011899:Ranitidine; D016190:Carboplatin; D017239:Paclitaxel